222 related articles for article (PubMed ID: 20600733)
1. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
[TBL] [Abstract][Full Text] [Related]
2. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
[TBL] [Abstract][Full Text] [Related]
3. OPA quantification of amino groups at the surface of lipidic nanocapsules (LNCs) for ligand coupling improvement.
Perrier T; Fouchet F; Bastiat G; Saulnier P; Benoît JP
Int J Pharm; 2011 Oct; 419(1-2):266-70. PubMed ID: 21839821
[TBL] [Abstract][Full Text] [Related]
4. Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion.
Anton N; Gayet P; Benoit JP; Saulnier P
Int J Pharm; 2007 Nov; 344(1-2):44-52. PubMed ID: 17592746
[TBL] [Abstract][Full Text] [Related]
5. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
[TBL] [Abstract][Full Text] [Related]
6. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
Ji X; Gao Y; Chen L; Zhang Z; Deng Y; Li Y
Int J Pharm; 2012 Jan; 422(1-2):390-7. PubMed ID: 22001531
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
[TBL] [Abstract][Full Text] [Related]
8. Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells.
Maupas C; Moulari B; Béduneau A; Lamprecht A; Pellequer Y
Int J Pharm; 2011 Jun; 411(1-2):136-41. PubMed ID: 21463666
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133.
Bourseau-Guilmain E; Béjaud J; Griveau A; Lautram N; Hindré F; Weyland M; Benoit JP; Garcion E
Int J Pharm; 2012 Feb; 423(1):93-101. PubMed ID: 21683129
[TBL] [Abstract][Full Text] [Related]
10. In vitro drug release mechanism from lipid nanocapsules (LNC).
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Int J Pharm; 2010 May; 390(2):208-13. PubMed ID: 20149853
[TBL] [Abstract][Full Text] [Related]
11. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
[TBL] [Abstract][Full Text] [Related]
12. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes.
Letchford K; Burt H
Eur J Pharm Biopharm; 2007 Mar; 65(3):259-69. PubMed ID: 17196803
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
14. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.
David S; Carmoy N; Resnier P; Denis C; Misery L; Pitard B; Benoit JP; Passirani C; Montier T
Int J Pharm; 2012 Feb; 423(1):108-15. PubMed ID: 21726617
[TBL] [Abstract][Full Text] [Related]
16. Layer-by-layer surface modification of lipid nanocapsules.
Hirsjärvi S; Qiao Y; Royere A; Bibette J; Benoit JP
Eur J Pharm Biopharm; 2010 Oct; 76(2):200-7. PubMed ID: 20656028
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
[TBL] [Abstract][Full Text] [Related]
18. Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers.
Umerska A; Mouzouvi CR; Bigot A; Saulnier P
Int J Pharm; 2015 Sep; 493(1-2):224-32. PubMed ID: 26183331
[TBL] [Abstract][Full Text] [Related]
19. The influence of lipid nanocapsule composition on their size distribution.
Heurtault B; Saulnier P; Pech B; Venier-Julienne MC; Proust JE; Phan-Tan-Luu R; Benoît JP
Eur J Pharm Sci; 2003 Jan; 18(1):55-61. PubMed ID: 12554073
[TBL] [Abstract][Full Text] [Related]
20. Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative.
Basile L; Passirani C; Huynh NT; Béjaud J; Benoit JP; Puglisi G; Pignatello R
Int J Pharm; 2012 Apr; 426(1-2):231-238. PubMed ID: 22306040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]